⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14997036 | 0.75 | — | — | |
| SCHEMBL10442896 | 0.67 | CA1 (0.46) | — | |
| SCHEMBL136797 | 0.67 | — | — | |
| SCHEMBL379827 | 0.67 | — | — | |
| Methanesulfonamide SCHEMBL1817 | 0.64 | — | — | |
| SCHEMBL14328762 | 0.64 | — | — | |
| SCHEMBL15369281 | 0.64 | — | — | |
| SCHEMBL3180205 | 0.64 | — | — | |
| SCHEMBL17915464 | 0.64 | — | — | |
| SCHEMBL17956089 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11401430-B2 | White ink, ink set, and recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2022-08-02 | — | — | US | disclosed |
| US-20210363367-A1 | WHITE INK, INK SET, AND RECORDING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2021-11-25 | — | — | US | disclosed |
| EP-3778796-A1 | WHITE INK, INK SET, AND RECORDING METHOD | Nippon Kayaku Kabushiki Kaisha (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-10640665-B2 | Ink composition and textile printing method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2020-05-05 | — | — | US | disclosed |
| US-20170137648-A1 | INK COMPOSITION AND TEXTILE PRINTING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2017-05-18 | — | — | US | disclosed |
| US-8569378-B2 | p27 protein inducer | Sakai, Toshiyuki (JP) | 2013-10-29 | — | — | US | disclosed |
| US-20110009398-A1 | p27 Protein Inducer | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-1268396-B1 | DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY | PFIZER LTD (GB) | 2005-07-20 | — | — | EP | disclosed |
| EP-1268396-A1 | DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY | Pfizer Limited (GB) | 2003-01-02 | — | — | EP | disclosed |
| US-6448293-B1 | TREATMENT OR PREVENTION OF A DISORDER IN WHICH THE REGULATION OF MONOAMINE TRANSPORTER FUNCTION IS IMPLICATED, SUCH AS PREMATURE EJACULATION. | PFIZER INC. | 2002-09-10 | — | — | US | disclosed |
| US-20020052395-A1 | Diphenyl ether compounds useful in therapy | ANDREWS MARK DAVID (GB) | 2002-05-02 | — | — | US | disclosed |
| WO-2001072687-A1 | DIPHENYL ETHER COMPOUNDS USEFUL IN THERAPY | PFIZER LIMITED (GB) | 2001-10-04 | — | — | WO | disclosed |